EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the Potential of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 as Promising Psychobiotics Using SHIME

Fellipe Lopes De Oliveira iD, Mateus Kawata Salgaço iD, Marina Toscano de Oliveira, Victoria Mesa, Adilson Sartoratto iD, Antonio Medeiros Peregrino iD, Williams Santos Ramos iD, Katia Sivieri

Nutrients · 21.03.2023 · 15 (6) · 1521

DOI: 10.3390/nu15061521 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 21.03.2023. Verfasst von Fellipe Lopes De Oliveira und 7 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Food, Nutrition, and Food Engineering, Campus Araraquara, São Paulo State University (UNESP), Araraquara 14800-060, SP, Brazil. Hauptthemen laut MEDLINE: Bifidobacterium longum, Lactobacillus helveticus, Anti-Anxiety Agents, Probiotics. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Apsen Farmacêutica, Apsen Farmacêutica company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psychobiotics are probiotics that have the characteristics of modulating central nervous system (CNS) functions or reconciled actions by the gut–brain axis (GBA) through neural, humoral and metabolic pathways to improve gastrointestinal activity as well as anxiolytic and even antidepressant abilities. The aim of this work was to evaluate the effect of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 on the gut microbiota of mildly anxious adults using SHIME®. The protocol included a one-week control period and two weeks of treatment with L. helveticus R0052 and B. longum R0175. Ammonia (NH4+), short chain fatty acids (SCFAs), gamma-aminobutyric acid (GABA), cytokines and microbiota composition were determined. Probiotic strains decreased significantly throughout the gastric phase. The highest survival rates were exhibited by L. helveticus R0052 (81.58%; 77.22%) after the gastric and intestinal phase when compared to B. longum (68.80%; 64.64%). At the genus level, a taxonomic assignment performed in the ascending colon in the SHIME® model showed that probiotics (7 and 14 days) significantly (p < 0.005) increased the abundance of Lactobacillus and Olsenella and significantly decreased Lachnospira and Escheria-Shigella. The probiotic treatment (7 and 14 days) decreased (p < 0.001) NH4+ production when compared to the control period. For SCFAs, we observed after probiotic treatment (14 days) an increase (p < 0.001) in acetic acid production and total SCFAs when compared to the control period. Probiotic treatment increased (p < 0.001) the secretion of anti-inflammatory (IL-6 and IL-10) and decreased (p < 0.001) pro-inflammatory cytokines (TNF-alpha) when compared to the control period. The gut–brain axis plays an important role in the gut microbiota, producing SCFAs and GABA, stimulating the production of anti-anxiety homeostasis. The signature of the microbiota in anxiety disorders provides a promising direction for the prevention of mental illness and opens a new perspective for using the psychobiotic as a main actor of therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bifidobacterium longumLactobacillus helveticusAnti-Anxiety AgentsProbioticsHumansAdultAnxietyFatty Acids, VolatileCytokines

Stichwörter der Autor:innen

colonic fermentationmicrobiota–brain-axispsychobiotic

Substanzen

Anti-Anxiety AgentsFatty Acids, VolatileCytokines

Autor:innen und Institutionen

  • Graduate Program in Food, Nutrition, and Food Engineering, Campus Araraquara, São Paulo State University (UNESP), Araraquara 14800-060, SP, Brazil.
  • University of Araraquara-UNIARA, Araraquara 14801-320, SP, Brazil.
  • Université Paris Cité, INSERM, UMR-S 1139 (3PHM), Faculty of Pharmacy, F-75006 Paris, France.
  • Food and Human Nutrition Research Group, School of Nutrition and Dietetics, Universidad de Antioquia (UdeA), Medellín 050010, Antioquia, Colombia.
  • CPQBA-UNICAMP, Paulínia 13148-218, SP, Brazil.
  • Psychiatric Department, Pernambuco State University (UPE), Recife 50100-010, PE, Brazil.

ORCID-Profile: Fellipe Lopes De Oliveira, Mateus Kawata Salgaço, Adilson Sartoratto, Antonio Medeiros Peregrino, Williams Santos Ramos

Förderung

  • Apsen Farmacêutica
  • Apsen Farmacêutica company

Zitieren

APA

De Oliveira, F. L., Salgaço, M. K., de Oliveira, M. T., Mesa, V., Sartoratto, A., Peregrino, A. M., Ramos, W. S., & Sivieri, K. (2023). Exploring the Potential of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 as Promising Psychobiotics Using SHIME. Nutrients, 15(6), 1521. https://doi.org/10.3390/nu15061521

Vancouver

De Oliveira FL, Salgaço MK, de Oliveira MT, Mesa V, Sartoratto A, Peregrino AM, et al. Exploring the Potential of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 as Promising Psychobiotics Using SHIME. Nutrients. 2023;15(6):1521. doi:10.3390/nu15061521

BibTeX
@article{DeOliveira2023,
  author = {De Oliveira, Fellipe Lopes and Salgaço, Mateus Kawata and de Oliveira, Marina Toscano and Mesa, Victoria and Sartoratto, Adilson and Peregrino, Antonio Medeiros and Ramos, Williams Santos and Sivieri, Katia},
  title = {Exploring the Potential of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 as Promising Psychobiotics Using SHIME},
  journal = {Nutrients},
  year = {2023},
  volume = {15},
  number = {6},
  pages = {1521},
  doi = {10.3390/nu15061521}
}
Kostenlos starten →